Advances in co-opting anti-depressant drugs in glioma therapy
- PMID: 36543105
- PMCID: PMC9797942
- DOI: 10.1016/j.xcrm.2022.100837
Advances in co-opting anti-depressant drugs in glioma therapy
Abstract
A study by Chryplewicz et al. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compartments in glioma.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity.Cancer Cell. 2022 Oct 10;40(10):1111-1127.e9. doi: 10.1016/j.ccell.2022.08.014. Epub 2022 Sep 15. Cancer Cell. 2022. PMID: 36113478 Free PMC article.
References
-
- Winkler F., Kozin S., Tong R., Chae S., Booth M., Garkavtsev I., Xu L., Hicklin D., Fukumura D., Ditomaso E. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. 2004;6:553–563. doi: 10.1016/s1535-6108(04)00305-8. - DOI - PubMed
-
- Keunen O., Johansson M., Oudin A., Sanzey M., Rahim S.A.A., Fack F., Thorsen F., Taxt T., Bartos M., Jirik R., et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc. Natl. Acad. Sci. USA. 2011;108:3749–3754. doi: 10.1073/pnas.1014480108. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources